Rhythm Pharmaceuticals Inc (RYTM)

Health Care·equity

$90.78

+1.27% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

37/ 100

Score level

Below average

6 of 6 checks had data

Smart-money score is below the middle — score for how it compares with the broader market is on the low side.

RYTM scores higher than 46% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Rhythm Pharmaceuticals Inc (RYTM) scores 37 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 1.97× 30-day average
52-week range: 74.50 – 122.20
Market cap: $6.73B
Earnings date: 2 Nov 2026

Volume: 1,411,378
Avg. volume (30d): 717,384

Open: 89.67
Previous close: 89.64
Day's range (regular session): 89.41 – 93.35

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 2.12
P/E (TTM): —
EPS (TTM): -3.05

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for RYTM

26 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for RYTM. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about RYTM right now

Rhythm Pharmaceuticals Inc (RYTM) currently scores 37/100 on the Market Census six-factor composite, at the Below average score level. RYTM is +1.27% on the day and -2.54% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of RYTM's data reads poorly than well. The level is a "look before you act" flag. It is not advice. RYTM's strongest factor is price trend at 51/100 — a fairly good read on which way the price has been going. The weakest factor is insider trades at 18/100 — a well below average read on insider buying and selling. Insider filings for RYTM lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See RYTM in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score